Short Interest Reporting: Could Amsurg Incorporated (NASDAQ:AMSG) Skyrocket? The Stock Has Too Many Sellers

November 24, 2016 - By Marie Mckinney   ·   0 Comments

Short Interest Reporting: Could Amsurg Incorporated (NASDAQ:AMSG) Skyrocket? The Stock Has Too Many Sellers

The stock of Amsurg Incorporated (NASDAQ:AMSG) registered an increase of 6.74% in short interest. AMSG’s total short interest was 13.39M shares in November as published by FINRA. Its up 6.74% from 12.55M shares, reported previously. With 1.24 million shares average volume, it will take short sellers 11 days to cover their AMSG’s short positions. The short interest to Amsurg Incorporated’s float is 25.5%. The stock increased 1.18% or $0.77 on November 23, hitting $65.75. About 919,716 shares traded hands. Amsurg Corp (NASDAQ:AMSG) has declined 18.63% since April 22, 2016 and is downtrending. It has underperformed by 24.04% the S&P500.

AmSurg Corp. is a surgical center and physician services company. The company has a market cap of $3.46 billion. The Firm is an owner and operator of ambulatory surgery centers in the United States. It has a 21.51 P/E ratio. The Firm is also a well-known provider of outsourced physician services in the areas of anesthesiology, children’s services, emergency medicine and radiology.

Insitutional Activity: The institutional sentiment increased to 1.33 in Q2 2016. Its up 0.47, from 0.86 in 2016Q1. The ratio improved, as 29 funds sold all Amsurg Corp shares owned while 118 reduced positions. 39 funds bought stakes while 88 increased positions. They now own 52.50 million shares or 5.39% less from 55.50 million shares in 2016Q1.
The Pennsylvania-based Stoneridge has invested 0.09% in Amsurg Corp (NASDAQ:AMSG). Zurcher Kantonalbank (Zurich Cantonalbank) last reported 1,424 shares in the company. Gabelli Funds Limited Liability holds 33,000 shares or 0.02% of its portfolio. Weaver C Barksdale And last reported 0.02% of its portfolio in the stock. Raymond James Associate holds 0.06% of its portfolio in Amsurg Corp (NASDAQ:AMSG) for 264,686 shares. Blackrock Fund Advsrs owns 2.10 million shares or 0.04% of their US portfolio. Moreover, Smith Asset Mngmt L P has 0% invested in Amsurg Corp (NASDAQ:AMSG) for 1,720 shares. Texas Permanent School Fund has 0.04% invested in the company for 41,340 shares. Gemmer Asset Management Ltd Liability holds 0% of its portfolio in Amsurg Corp (NASDAQ:AMSG) for 78 shares. Hillsdale Invest Mgmt holds 0.11% or 4,800 shares in its portfolio. Ahl Prtn Limited Liability Partnership owns 6,872 shares or 0.03% of their US portfolio. Glenmede Trust Com Na accumulated 0% or 2,852 shares. Suntrust Banks Inc holds 0% of its portfolio in Amsurg Corp (NASDAQ:AMSG) for 2,876 shares. Firstmerit Natl Bank N A Trustee accumulated 0.03% or 5,073 shares. Mutual Of America Capital Mgmt Limited Liability Corporation, a New York-based fund reported 98,364 shares.

Insider Transactions: Since August 18, 2016, the stock had 0 buys, and 2 insider sales for $960,075 net activity. Coward Robert Jon sold $477,375 worth of stock or 7,500 shares.

Amsurg Corp (NASDAQ:AMSG) Ratings Coverage

Out of 9 analysts covering AmSurg (NASDAQ:AMSG), 7 rate it a “Buy”, 0 “Sell”, while 2 “Hold”. This means 78% are positive. AmSurg has been the topic of 14 analyst reports since August 6, 2015 according to StockzIntelligence Inc. The company was initiated on Monday, September 26 by Citigroup. Mizuho initiated Amsurg Corp (NASDAQ:AMSG) on Friday, April 1 with “Buy” rating. The rating was upgraded by Wells Fargo to “Outperform” on Wednesday, November 2. The rating was reinitiated by Goldman Sachs on Monday, November 30 with “Buy”. Mizuho maintained the stock with “Buy” rating in Friday, June 24 report. The firm earned “Equal-Weight” rating on Wednesday, January 6 by Barclays Capital. The stock of Amsurg Corp (NASDAQ:AMSG) has “Neutral” rating given on Wednesday, November 9 by Mizuho. The company was initiated on Wednesday, September 16 by JP Morgan. The stock has “Market Perform” rating given by Wells Fargo on Wednesday, June 15. Stephens maintained it with “Overweight” rating and $97 target price in Monday, December 14 report.

AMSG Company Profile

AmSurg Corp., incorporated on the March 6, 1992, is a surgical center and physician services company. The Firm is an owner and operator of ambulatory surgery centers (ASCs) in the United States. The Firm is also a well-known provider of outsourced physician services in the areas of anesthesiology, children’s services, emergency medicine and radiology. It operates through two divisions: ambulatory services and physician services. The Firm operates approximately 260 ASCs in over 30 states and the District of Columbia in partnership with approximately 2,000 physicians, and provides physician services to over 450 healthcare facilities in approximately 30 states.

Another recent and important Amsurg Corp (NASDAQ:AMSG) news was published by Businesswire.com which published an article titled: “Envision and AMSURG Announce Pricing of $550 Million Senior Notes Offering by …” on November 16, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Marie Mckinney


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>